According to The Insight Partners' research, the North America CT Scanner Market was valued at US$ 2,959.0 Million in 2024 and is expected to reach US$ 4,101.1 Million by 2031, registering a CAGR of 4.9% from 2025 to 2031.
Increasing burden of chronic diseases and AI-driven workflow automation are among the critical factors attributed to the North America CT scanner market expansion.
The global surge in chronic and noncommunicable diseases has become a central driver for the CT scanner market. Conditions such as cardiovascular disease, cancer, stroke, and neurological disorders are increasingly prevalent due to aging populations, sedentary lifestyles, urbanization, and poor dietary habits. These diseases often require advanced diagnostic imaging to ensure early detection, precise localization, and treatment planning, roles in which CT (Computed Tomography) plays a critical part. Unlike many other imaging modalities, CT scans provide high-resolution, cross-sectional images quickly and noninvasively, making them indispensable in emergency, outpatient, and inpatient diagnostic workflows. In oncology, for instance, CT is used extensively for tumor staging and monitoring treatment response. In cardiology, it supports calcium scoring, angiography, and assessment of coronary artery disease. As populations in both developed and emerging economies rapidly age, the overall demand for diagnostic imaging-particularly modalities such as CT-is increasing sharply. In the US, Europe, China, and India, healthcare systems are experiencing a sustained increase in scan volumes as chronic illnesses become a year-round healthcare burden. This epidemiological shift is pressuring hospitals, diagnostic labs, and outpatient imaging centers to invest in more CT systems, often with advanced functionalities to meet evolving clinical demands. The chronic disease trend sustains baseline demand for CT scanners and compels healthcare systems to upgrade their existing equipment with newer, more capable technologies that offer faster scans, reduced radiation exposure, and improved diagnostic accuracy.
On the contrary, high capital and maintenance costs, radiation exposure and regulatory constraints, shortage of skilled personnel hamper the growth of North America CT scanner market.
North America CT Scanner Market Segmentation Analysis:
- By Type, the North America CT Scanner Market is segmented into Stationary CT Scanners and Portable CT Scanners. The Stationary CT Scanners segment is projected to expand at a CAGR of 4.2% during 2025 - 2031.
- By Architecture, the North America CT Scanner Market is segmented into C-arm CT Scanners and O-arm CT Scanners. The C-arm CT Scanners segment is projected to expand at a CAGR of 5.4% during 2025 - 2031.
- By Technology, the North America CT Scanner Market is segmented into High Slice CT, Mid size CT, Low Slice CT, and Cone Beam CT. The High Slice CT segment is projected to expand at a CAGR of 5.5% during 2025 - 2031.
- By Application, the North America CT Scanner Market is segmented into Neurology, Oncology, Orthopedics, and Others. The Neurology segment is projected to expand at a CAGR of 5.5% during 2025 - 2031.
- By End User, the North America CT Scanner Market is segmented into Hospitals, Diagnostic Centers, Veterinary Clinics, and Research Lab. The Hospitals segment is projected to expand at a CAGR of 5.8% during 2025 - 2031.
By country, the North America CT Scanner Market is categorized into the United States, Canada, and Mexico. The United States is projected to expand at a CAGR of 5.1% during 2025 - 2031.
Key players operating in the CT Scanner Market are Medtronic Plc, Koninklijke Philips NV, GE HealthCare Technologies Inc, PLANMED OY, Canon Medical Systems Corp, Accuray Incorporated, Neusoft Medical Systems, Siemens Healthineers AG, Hitachi High-Tech Corp, and Shanghai United Imaging Healthcare Co., LTD, among others.
- In September 2025, GE HealthCare recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Revolution Vibe CT system, which the company said is squarely aimed at the rapidly growing coronary computed tomography angiography (CCTA) market. The company also announced its first commercial install.
- In June 2025, In a significant move to strengthen Indonesia's healthcare infrastructure, PT Kalbe Farma Tbk (Kalbe) and GE HealthCare have officially inaugurated the country's first production facility dedicated to manufacturing technologically advanced CT (Computed Tomography) scanners. Located at PT Forsta Kalmedic Global (Forsta) in Bogor. The facility is a milestone in localizing advanced medical device production and enhancing diagnostic capabilities across the nation.
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com